Bipartisan Michigan lawmakers unveil a bill subjecting US-China biotech deals to outbound investment screening, citing national security risks.
Rep. John Moolenaar (R-MI) (Lenin Nolly/Sipa USA/Sipa via AP Images)
June 2, 2026 08:00 AM EDT
DealsChinaPharmaFDA+
Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech
Max Bayer
If enacted, BINSA would give lawmakers the right to monitor and restrict American companies from signing biotech and…
Chinese pharma companies are still striking global deals, but rising regulatory pressure is forcing buyers and sellers to rethink…
They're laying the groundwork for legislation and regulation to counter Chinese biopharma companies.
Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic…
美国国会两党议员星期二(6月2日)联合提出一项立法，旨在防止美国制药和生物技术领域的投资流向中国企业。提出该项立法的国会议员表示，此举对于保护美国的药品供应链和研发基础、防范外国对手渗透至关重要。
A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S.…
